- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neuroectodermal Tumors, Primitive, Peripheral in South Africa
Total 612 results
-
HutchmedNo longer available
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
Bristol-Myers SquibbCompletedMelanomaSouth Africa, United States, Spain, France, Italy, Belgium, Austria, Israel, Germany, Norway, Canada, Brazil, Poland, Denmark, Czech Republic, Russian Federation, Ukraine, Argentina
-
Bristol-Myers SquibbCompletedMelanomaAustralia, France, Italy, Poland, United Kingdom, United States, Spain, Belgium, Denmark, Germany, Norway, Switzerland, Argentina, Austria, Sweden, Czechia, Hungary, Netherlands, Mexico, Canada, Israel, South Africa
-
Barwon HealthAustralasian Gastro-Intestinal Trials Group; Deakin University; Specialised Therapeutics...UnknownGastrointestinal Neuroendocrine CarcinomasAustralia
-
Novartis PharmaceuticalsCompletedSymptomatic Refractory Resistant Carcinoid DiseaseUnited Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
-
Myrexis Inc.Completed
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIAustria, Netherlands, Australia, Sweden
-
Immutep Australia Pty. Ltd.CompletedStage IV Melanoma | Stage III MelanomaAustralia
-
Evaxion Biotech A/SMerck Sharp & Dohme LLCRecruitingMelanoma Stage IV | Melanoma Stage IIIAustralia
-
Trans Tasman Radiation Oncology GroupCompleted
-
GlaxoSmithKlineCompletedMelanomaAustralia, United States
-
NuvOx LLCThe AlfredCompletedGlioblastoma MultiformeAustralia
-
Trans Tasman Radiation Oncology GroupUniversity Medical Center Groningen; Australian and New Zealand Intensive Care...CompletedLymph Node Disease | Malignant MelanomaAustralia, New Zealand, Netherlands, Brazil
-
Erasmus Medical CenterRecruiting
-
InxMed (Shanghai) Co., Ltd.RecruitingMetastatic MelanomaUnited States, Australia
-
Genentech, Inc.CompletedMalignant MelanomaUnited States, Australia
-
Aura BiosciencesTerminatedChoroidal Melanoma | Indeterminate LesionsUnited States
-
AbbottBiogenTerminated
-
Immunocore LtdRecruitingAdvanced MelanomaUnited States, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Australia, Puerto Rico, Switzerland, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI); SWOG Cancer Research NetworkCompletedSarcomaUnited States, Canada, Australia, Switzerland, Puerto Rico, Netherlands, New Zealand
-
Xenova BiomedixUnknownBrain and Central Nervous System TumorsUnited States
-
Gilead SciencesTerminatedGlioblastoma MultiformeAustralia
-
ViralyticsCompletedMalignant MelanomaAustralia
-
Cancer Insight, LLCElios Therapeutics, LLCCompleted
-
Ludwig Institute for Cancer ResearchInstitute of Cancer Research, United KingdomCompletedMelanomaUnited Kingdom, Australia, New Zealand
-
Xennials Therapeutics Australia Pty LtdPinotbio, Inc.TerminatedAdvanced Solid Tumor | High-grade Glioma | Platinum-Resistant Ovarian Cancer | Platinum-Resistant Urothelial CarcinomaAustralia
-
AmgenMerck Sharp & Dohme LLCTerminatedMelanomaUnited States, Finland, France, Germany, Italy, Canada, Czechia, Poland, Switzerland, Korea, Republic of, Russian Federation, United Kingdom, Australia, Netherlands, Spain, Austria, Belgium, Hungary, Portugal, Greece, South Africa
-
BioVex LimitedAmgenCompletedMelanomaUnited States, United Kingdom, Canada, South Africa
-
NeotropixUnknownCarcinoid | NeuroendocrineUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedAdult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Recurrent Adult Brain Tumor | Tumors Metastatic to Brain | Adult Anaplastic OligoastrocytomaUnited States
-
IpsenCompletedCarcinoid SyndromeUnited States, Turkey, Brazil, India, Ukraine, South Africa, Czechia, Latvia, Poland, Russian Federation, Serbia
-
PDL BioPharma, Inc.CompletedMelanoma | MetastasesUnited States
-
IO BiotechMerck Sharp & Dohme LLC; Syneos HealthActive, not recruitingMetastatic Melanoma | Unresectable MelanomaHungary, Spain, United Kingdom, Australia, France, Italy, United States, Denmark, Germany, Israel, Czechia, Belgium, Netherlands, Turkey, Poland, South Africa
-
GlaxoSmithKlineCompleted
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials LimitedRecruitingUnresectable/Metastatic MelanomaCanada, Australia
-
Jennerex BiotherapeuticsCompleted
-
Bristol-Myers SquibbMedarexCompletedMelanomaUnited States, Brazil, France, Italy, South Africa, United Kingdom, Argentina, Australia, Canada, Ireland, Israel, Russian Federation, Spain, Belgium, Germany, Portugal, Chile, Austria, Poland, Netherlands, Ukraine, Czech Republic, ... and more
-
AttenuonUnknown
-
CancerVax CorporationUnknownMelanoma (Skin)United States, Australia
-
Hoffmann-La RocheCompleted
-
National Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Melanoma and Skin Cancer Trials LimitedBristol-Myers Squibb; Amgen; Peter MacCallum Cancer Centre, AustraliaActive, not recruitingMelanoma | Melanoma Stage Iv | Melanoma Stage IiiAustralia
-
Piramal Enterprises LimitedMelanoma Research Foundation Breakthrough ConsortiumSuspendedAdvanced or Inoperable Malignant Melanoma With BRAF MutationUnited States
-
BayerAmgenCompletedMelanoma | CancerUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
AmpliMed CorporationCompletedMalignant MelanomaUnited States
-
Bristol-Myers SquibbCompletedMelanomaItaly, France, Spain, Australia
-
Medical University of South CarolinaCompletedImaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma MultiformeGlioblastomaUnited States